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The exon junction complex (EJC) is a key regulator
of posttranscriptional mRNA fate and binds to
mRNA during splicing. Although the composition of
EJCs is well understood, the mechanism mediating
splicing-dependent EJC assembly and the factor(s)
recruiting the EJC remain elusive. Here, we identify
CWC22 as an essential splicing factor that is required
for EJC assembly. In CWC22-depleted cells, pre-
mRNA splicing is impaired but is rescued by a central
fragment of CWC22. We show that the MIF4G
domain of CWC22 initiates EJC assembly via a direct
interaction with the EJC core protein eIF4A3, and
we characterize mutations in eIF4A3 that abolish
binding to CWC22. These eIF4A3 mutants efficiently
nucleate splicing-independent recombinant EJC
core complexes, but they fail to support splicing-
dependent EJC deposition. Our work establishes
a direct link between the splicing machinery and
the EJC, hence uncovering a molecular interaction
at the center of a posttranscriptional gene regulation
network.INTRODUCTION
The molecular apparatus required for eukaryotic gene expres-
sion forms a network that is able to communicate across the
nuclear envelope and includes the transcription, splicing, and
translation machinery (Moore and Proudfoot, 2009). Interac-
tions between the different processing steps are mediated by
RNA-binding proteins that form messenger ribonucleoprotein
complexes (mRNPs) (Rodrı´guez-Navarro and Hurt, 2011). The
protein composition of the mRNP reflects the history and deter-
mines the fate of each mRNA molecule. A key regulator within
this mRNP network is the exon junction complex (EJC).
The EJC is a protein complex that assembles on spliced
mRNA 20–24 nts upstream of exon-exon boundaries in a
sequence-independent manner (Le Hir et al., 2000). It remains
bound to the mRNA, thereby marking the position of splice
sites, until it is disassembled during translation in the cytoplasm
(Gehring et al., 2009b). In mammals, EJCs are involved in
the detection of mRNAs containing premature translation termi-
nation codons (Lykke-Andersen et al., 2001). Furthermore,454 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Authorcomponents of the EJC have been shown to be responsible for
the increased export and translational efficiency of spliced
mRNAs (Le Hir et al., 2001; Ma et al., 2008). They also regulate
the splicing of a subset of pre-mRNAs, particularly those
containing long introns, such as mitogen-activated protein
kinase (MAPK) (Ashton-Beaucage et al., 2010; Roignant and
Treisman, 2010).
The EJC core consists of four subunits, eIF4A3 (DDX48),
MAGOH, Y14 (RBM8A), and BTZ (CASC3, MLN51), of which
MAGOH and Y14 constitute a stable heterodimer (Tange et al.,
2005). The crystal structure of the EJC core reveals how these
subunits are organized into a complex (Andersen et al., 2006;
Bono et al., 2006). In the presence of ATP, the DEAD-box heli-
case eIF4A3 adopts a closed conformation and binds to RNA.
The closed conformation and therefore the RNA interaction is
stabilized upon binding of the MAGOH-Y14 heterodimer to
eIF4A3 (Ballut et al., 2005). The core component BTZ binds to
eIF4A3 in a conformation-independent manner, although the
interaction is stabilized within the EJC by additional protein-
protein and protein-RNA interactions. Although the EJC can
form spontaneously in vitro from recombinant components,
its assembly in living cells or cell extracts is strictly splicing
dependent (Bono and Gehring, 2011). However, the underlying
molecular mechanism of EJC loading, the reason for the splicing
dependence, and the spliceosomal proteins involved in EJC
assembly remain unknown.
Here, we show that the protein CWC22 is required for pre-
mRNA splicing in mammalian cells and represents an essential
EJC loading factor. CWC22 interacts directly with eIF4A3
via its MIF4G domain, and this interaction contributes to the
splicing-dependent assembly of EJCs. In cells depleted of
CWC22, pre-mRNA splicing is impaired, while a construct com-
prising the MIF4G andMA3 domain of CWC22 suffices to rescue
the splicing defect. Taken together, our results highlight the
functional interconnection between splicing and EJC recruit-
ment and indicate that eIF4G-eIF4A-like interactions emerge
as common principle in mRNP remodeling.
RESULTS
CWC22 Is an eIF4A3-Interacting Protein
The EJC core protein eIF4A3 directly contacts RNA and there-
fore serves as an interaction platform for all other EJC proteins
(Andersen et al., 2006; Bono et al., 2006). In order to identify
putative factors within the spliceosome that recruit eIF4A3
and initiate EJC assembly, we searched the human genomes
Figure 1. eIF4A3 Binds to CWC22 via Its MIF4G Domain
(A) FLAG-CWC22 was immunoprecipitated from RNase-A-treated cell lysates. Coprecipitated endogenous proteins were detected by immunostaining with
specific antibodies. Unfused FLAG was used as a negative control.
(B) FLAG-eIF4A3 was immunoprecipitated as described in (A). Asterisks denote nonspecific bands.
(C) Schematic representation of N- and C-terminal truncations of CWC22 used for FLAG immunoprecipitation.
(D) FLAG-CWC22 deletion mutants were immunoprecipitated as described in (A).
(E) Immunoprecipitation of recombinant CWC22 and eIF4A3. FLAG-Strep-eIF4A3, GST-CWC22 (110–409),GST-CWC22 (110–665), and GST-CWC22 (340–665)
were purified from E.coli, incubated in binding buffer, and immunoprecipitated. Proteins were separated by SDS-PAGE and stained with Coomassie. S2:
Strep-tag.
(F) FLAG-CWC22 and FLAG-BTZ were immunoprecipitated as described in (A).
(G) Immunoprecipitation of CWC22 and EJC proteins in vitro. Recombinant Strep-eIF4A3, MAGOH, Y14-Strep, BTZ (110–372)-Strep (lanes 1 and 2), or Flag-BTZ
(110–372)-Strep (lane 3) were incubated under EJC-assembly conditions (see Experimental Procedures) in the presence (lane 2) or absence (lanes 1 and 3) of
recombinant GST-CWC22 (110–409)-Flag. Immunoprecipitation was performed as in (E).
See also Figure S1.database for spliceosomal proteins with homology to known
eIF4A3-interacting proteins. Interestingly, we found that
NOM1, a protein previously shown to interact with eIF4A3 during
rRNA biogenesis in yeast and humans, shares significant
sequence identity with the spliceosomal protein CWC22 (Fig-
ure S1). Notably, the highest sequence conservation between
CWC22 and NOM1 was found within their MIF4G (middle
domain of eukaryotic initiation factor 4G [eIF4G]) and MA3
domains. The MIF4G and MA3 domains of eIF4G have been
shown to confer eIF4A binding during eukaryotic translation
initiation (Marintchev et al., 2009), and likewise, mutations in
the MIF4G domain of NOM1 defined its genetic interaction
with eIF4A3 during pre-rRNA processing (Alexandrov et al.,
2011).
To test whether CWC22 is indeed an eIF4A3-interacting
factor, we immunoprecipitated FLAG-tagged CWC22 from
HeLa cell lysates treated with RNase A (Figure 1A) or RNase I
(Figure S1B) and analyzed the interaction with eIF4A3. Endoge-
nous eIF4A3 coprecipitated with FLAG-CWC22 (Figures 1A and
S1B), and this interaction was confirmed by the coprecipitation
of endogenous CWC22 with FLAG-eIF4A3 (Figures 1B andCelS1C). Notably, two bands of coprecipitated CWC22were visible,
suggesting that posttranslational modifications may modulate
its interaction with eIF4A3 (Figure 1B). The interaction of
eIF4A3 with CWC22 is specific, because the RNA-binding pro-
teins eIF4A1 and CBP80 fail to coprecipitate with CWC22 and
eIF4A3, respectively (Figures 1A, 1B, S1B, and S1C).
The high degree of sequence conservation between the
MIF4G and MA3 domains of NOM1 and CWC22 suggests that
either one or both of these domains are involved in the bind-
ing of eIF4A3. To identify the eIF4A3-interacting domain(s) of
CWC22, we performed coimmunoprecipitation experiments
with N- and C-terminal truncations of FLAG-CWC22 (Figures
1C and 1D). The minimal eIF4A3-binding module identified
consisted of the amino acid residues 110–409 of CWC22
(Figure 1D, lane 5). Notably, this part of CWC22 contains
the MIF4G domain. In contrast, the MA3-domain-containing
fragment (340–665) of CWC22 did not interact with eIF4A3
(Figure 1D, lane 6).
To analyze whether CWC22 interacts directly with eIF4A3, we
purified full-length FLAG-Strep-tagged eIF4A3 and GST-tagged
CWC22 from E. coli. We were not able to obtain the full-lengthl Reports 2, 454–461, September 27, 2012 ª2012 The Authors 455
CWC22 protein from bacterial cultures, but three truncated
versions, comprising residues 110–665, 110–409 and 340–665
of CWC22, were highly expressed. These recombinant CWC22
protein variants were preincubated with eIF4A3, and complex
formation was analyzed by FLAG immunoprecipitation (Fig-
ure 1E). Both MIF4G-containing variants of CWC22 (110–665
and 110–409) but not the MA3 domain (340–665) readily copuri-
fiedwith eIF4A3, clearly demonstrating that theMIF4G domain of
CWC22 directly interacts with eIF4A3 in vitro.
CWC22 Binds to eIF4A3 but Not MAGOH and Y14
Our data show that CWC22 directly binds eIF4A3, but whether
this interaction involves the other core EJC proteins remains
unsolved. To this end, we immunoprecipitated FLAG-BTZ
(110–372) and FLAG-CWC22 from HeLa cell lysates and
compared their interaction with the endogenous EJC core
proteins eIF4A3, Y14, and MAGOH (Figure 1F). Both FLAG-
BTZ (110–372) and FLAG-CWC22 copurified comparable
amounts of endogenous eIF4A3. In contrast to FLAG-BTZ
(110–372), FLAG-CWC22 did not coprecipitate the other EJC
core proteins MAGOH and Y14 (Figure 1F, lane 2). Likewise,
no interaction of BTZ with CWC22 was observed (Figure S1D).
This indicates that CWC22 specifically binds to eIF4A3 outside
of the assembled EJC.
This finding was confirmed in vitro with recombinant compo-
nents (Figure 1G). The human EJC core was assembled from
eIF4A3, MAGOH-Y14, and BTZ (110–372) as described previ-
ously (Ballut et al., 2005; Bono et al., 2006). Whereas FLAG-
BTZ (110–372) coprecipitated all three core proteins of the EJC
(lane 3), FLAG-CWC22 (110–409) coprecipitated only eIF4A3
and BTZ (lane 2). Although the short version of BTZ used here
is coprecipitated together with eIF4A3 by CWC22, the full-length
BTZ protein did not interact with CWC22 in cell lysates (Fig-
ure S1D). Hence, CWC22 recruits only eIF4A3 to the spliceo-
some, while the additional EJC components are presumably
loaded by an alternative factor.
CWC22 Is Required for Pre-mRNA Splicing in Humans
We know that in yeast, Cwc22 is an essential splicing factor that
is involved in the regulation of the first catalytic step via the
DExD/H-box helicase Prp2 (Yeh et al., 2011). In contrast, the
human CWC22 protein is only poorly characterized.
To assess whether human CWC22 is required for pre-mRNA
splicing, we used two different small-interfering RNAs (siRNAs)
to deplete CWC22 in human cell culture. In knockdown cells,
CWC22 protein levels were reduced to 20%, as shown by
immunoblotting (Figure 2A). Northern blot analysis revealed
that the levels of mature b-globin mRNA, expressed from an
intron-containing reporter plasmid, were clearly reduced in
CWC22-knockdown cells as compared to control cells (Fig-
ure 2B, lane 2; Figure S2C). At the same time, we observed
a higher molecular weight band on the Northern blot at the size
of the unspliced b-globin pre-mRNA.mRNAexpressed froma tri-
sosephosphate isomerase (TPI) reporter (Figure 2C) and a T cell
receptor (TCR) reporter (Figure S2D) showed a similar, but quan-
titatively more pronounced, effect. We used quantitative RT-
PCR with intron- and exon-specific primer pairs (Figure S2A) to
further analyze the b-globin and TPI mRNAs and pre-mRNAs456 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Authorfrom knockdown and control cells. In line with our Northern
blot results, the levels of the pre-mRNA-specific PCR product
were strongly increased, whereas the levels of the mRNA-
specific PCR product were reduced in CWC22-knockdown cells
(Figure 2D). To explore whether the CWC22 knockdown also
impinges on endogenously expressed mRNAs, we quantified
pre-mRNAs and mRNAs of two housekeeping genes, actin-
beta (ACTB) and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). Notably, the primer pairs amplify different regions of
pre-mRNA and mRNA, respectively, (Figure S2A) and therefore
cannot discriminate between unspliced and partially spliced
transcripts that may accumulate as a result of CWC22 depletion.
However, decreased amounts of the spliced mRNA and
increased amounts of the intron-containing pre-mRNA were
observed for both genes in CWC22-depleted cells (Figure 2D).
The splicing defect of CWC22-depleted cells was rescued by
the expression of siRNA-resistant CWC22 (Figure 2B, lane 3; Fig-
ure 2C, lane 3; Figure S2D, lane 3). This finding confirmed the
specificity of the knockdown and enabled us to test which of
the variants of CWC22 is sufficient to support splicing in HeLa
cells. We expressed the N- and C-terminal truncations of
CWC22 that were previously used to identify the binding domain
of eIF4A3 in CWC22-knockdown cells. Interestingly, the CWC22
fragment containing both the MIF4G domain and adjacent MA3
domain (residues 110–665) was able to rescue the splicing
defect. In contrast, the MIF4G domain (residues 110–409) or
the MA3 domain (340–665) alone was insufficient to restore
splicing in knockdown cells (Figure 2E), despite showing expres-
sion levels comparable to full-length CWC22 (Figure S2E).
Together, our data demonstrate that the depletion of CWC22
strongly impairs pre-mRNA splicing in human cells and suggest
a critical role for the MIF4G and MA3 domains during splicing.
The Interaction of eIF4A3 and CWC22 Displays
Characteristics of an eIF4A-eIF4G Complex
So far, we have demonstrated that the MIF4G domains of
CWC22 and eIF4A3 form a complex. Because of the high degree
of sequence conservation between the DExD/H-box helicases
eIF4A3 and eIF4A, the CWC22-eIF4A3 complex could resemble
the well-characterized eIF4G-eIF4A complex. To generate
a molecular model of the CWC22-eIF4A3 interaction, we super-
imposed the structures of eIF4A3 (Bono et al., 2006) and eIF4A
(Schu¨tz et al., 2008) and used the cocrystallized MIF4G of
eIF4G as surrogate of CWC22 (Figure 3A). On the basis of this
model, we generated mutants of CWC22 and eIF4A3 and tested
them for their ability to form the CWC22-eIF4A3 complex.
We identified mutations (DLYD270KLYK, TI276GD,
NFT301LAG), at three different positions in eIF4A3, that abol-
ished the interaction with endogenous CWC22 in FLAG-immu-
noprecipitation assays (Figures 3B and S3A). The same muta-
tions also abrogated the binding between recombinant eIF4A3
and CWC22 (110–409) (Figure 3C).
Likewise, the mutation of two amino acid residues at the pre-
dicted binding surface of CWC22 (NK171DE) impaired the co-
precipitation of endogenous eIF4A3 from cell lysates (Figure 3D)
as well as the interaction between recombinant eIF4A3 and
CWC22 (Figures 3E and S3B). Interestingly, the mutation at
position 171/172 of CWC22 maps to a 12-amino-acid-longs
Figure 2. CWC22 Is an Essential Splicing Factor in Human Cells
(A) siRNA knockdown of CWC22 in human cell culture. HeLa cells were transfected with siRNAs targeting CWC22 (CWC[A] and CWC[B]) or Luciferase (negative
control). The knockdown efficiency was assessed by immunoblotting with a CWC22-specific antibody. Tubulin served as a loading control.
(B, C, and E) Northern blot analysis of b-globin and TPI reporter mRNAs in CWC22-depleted cells.
(B and C) An intron-containing b-globin (B) or TPI (C) reporter was coexpressed with a transfection control (LacZ-HBB) and siRNA-resistant FLAG-CWC22R
(lane 3) or unfused FLAG (lanes 1 and 2) in CWC22-knockdown (lanes 2 and 3) and control cells (lane 1). The mRNA and pre-mRNA was detected by Northern
blotting with a specific probe. An asterisk denotes an unspecific band. The bottom panel (B) shows a shorter exposure of the fully spliced b-globin band.
(D) Expression levels of pre-mRNA and mRNA were determined by quantitative RT-PCR. Bars represent the fold change in mRNA or pre-mRNA levels upon
CWC22 depletion, and standard deviations are indicated by error bars. Numbers next to bars represent the calculated fold splicing inhibition (see Experimental
Procedures).
(E) CWC22-knockdown cells were cotransfected with the indicated N- andC-terminal truncations of FLAG-CWC22R and the b-globin reporter as described in (B).
An asterisk denotes an unspecific band.
See also Figure S2.conserved sequence motif in eIF4G that has been shown to
compose the largest contiguous interface with eIF4A in yeast
(Schu¨tz et al., 2008). Moreover, the corresponding surface resi-
dues of the yeast NOM1 ortholog, Sgd1p, mediate its genetic
interaction with yeast eIF4A3 (Fal1p) (Figure S1, asterisk)
(Alexandrov et al., 2011). The identification of binding residues
at the predicted eIF4A3-CWC22 interface thus corroborates
the hypothesis that CWC22 and eIF4A3 constitute an eIF4A-
eIF4G-like interaction pair.
Binding of eIF4A3 to CWC22 Is Required for Splicing-
Dependent EJC Assembly
Our data revealed that CWC22 is an essential splicing factor in
human cells and interacts with eIF4A3. Since EJC-assembly is
a strictly splicing-dependent process, we hypothesized that
CWC22 functionally bridges the spliceosome and the EJC.
To test the effect of CWC22 on EJC assembly in vitro, we
incubated purified CWC22 (110–409) with equal amounts ofCelrecombinant EJC core components eIF4A3, BTZ, Y14, and
MAGOH. In line with the results of our immunoprecipitations
from cell lysates (Figure 1F), CWC22 did not coprecipitate
together with FLAG-Y14 and the assembled EJC (Figure S4A,
lane 3). Interestingly, the presence of wild-type CWC22, but
not of the eIF4A3-interaction-deficient mutant of CWC22
(171DE), clearly reduced the amounts of coprecipitated eIF4A3
and BTZ (Figure S4A). Hence, the interaction of CWC22 with
eIF4A3 impairs the assembly of recombinant EJCs in vitro. This
suggests that additional spliceosomal factors or full-length
CWC22 are required in order to recapitulate splicing-dependent
EJC assembly in vitro.
Splicing-dependent EJC assembly has previously been
studied by means of in vitro splicing reactions (Gehring et al.,
2009a). Hence, we utilized splicing assays to test whether the
CWC22-binding-deficient eIF4A3 mutants (DLYD270KLYK,
TI276GD, NFT301LAG) are incorporated into EJCs. To this
end, FLAG-containing mRNPs were immunoprecipitated,l Reports 2, 454–461, September 27, 2012 ª2012 The Authors 457
Figure 3. The Interaction of eIF4A3 and
CWC22-MIF4G Features Characteristics of
the eIF4A-eIF4G Complex
(A) The crystal structure of eIF4A and the MIF4G
domain of eIF4G (left side, PDB 2VSO) was used
to generate a model (right side) of the eIF4A3-
CWC22 interaction by superposition of the struc-
tures of eIF4A3 (as part of the EJC; PDB 2JOS)
and eIF4A. Putative contact sites (depicted in red)
of eIF4A3 and CWC22 were mutated and char-
acterized in (B–E). The superposition was gener-
ated by DaliLite (Holm and Park, 2000); the draw-
ing was rendered with PyMOL (DeLano, 2010).
(B and C) Analysis of eIF4A3 mutant proteins.
(B) FLAG-eIF4A3 and mutants of FLAG-eIF4A3
were immunoprecipitated from RNase-A-treated
cell lysates. Coprecipitated endogenous CWC22
was detected by immunostaining with a specific
antibody.
(C) Recombinant Strep-eIF4A3, Strep-eIF4A3
mutants, and GST-CWC22 (110–409)-FLAG were
incubated in binding buffer and immunoprecipi-
tated. Proteins were separated by SDS-PAGE and
stained with Coomassie.
(D and E) Analysis of a CWC22 mutant protein.
(D) FLAG-CWC22 and FLAG-CWC22 (NK171DE)
were immunoprecipitated from RNase-A-treated
cell lysates. Coprecipitated endogenous eIF4A3
was detected by immunostaining with a specific
antibody.
(E) Recombinant FLAG-Strep-eIF4A3, GST-
CWC22 (110–409) and GST-CWC22 (110–409/
NK171DE) were incubated in binding buffer and
immunoprecipitated as described in (C).
See also Figure S3.followed by RNA extraction and denaturing PAGE. As expected,
wild-type FLAG-eIF4A3 specifically coprecipitated spliced
mRNA (Figure 4A, lane 2, top panel), demonstrating that it
had been incorporated into an EJC (Gehring et al., 2009a). In
contrast, none of the CWC22-binding-deficient variants of
eIF4A3 precipitated any mRNA, indicating that the inability
to interact with CWC22 prevents splicing-dependent EJC
assembly (Figure 4A, lanes 3–5). Likewise, only the wild-type
eIF4A3, but none of the mutants, precipitated splicing intermedi-
ates when the splicing reactions were stalled at the step of spli-
ceosomal C-complex formation (MINX-GG; Figure 4A, bottom
panel). Hence, CWC22 recruits eIF4A3 during the first catalytic
step of splicing and thereby initiates EJC assembly.
The mutated residues in eIF4A3 (DLYD270KLYK, TI276GD,
NFT301LAG) do not overlap with the interaction surfaces of
Y14, MAGOH, or BTZ on eIF4A3 (Figure S4B). Nevertheless,
we wanted to validate that the mutations do not disrupt the
interaction of eIF4A3 with the other EJC components. To this
end, we used recombinant proteins to assemble a splicing-
independent EJC in vitro. Recombinant EJCs were assembled458 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Authorsfrom the core proteins eIF4A3, Y14,
MAGOH, and FLAG-BTZ (110–372) and
immunoprecipitated via FLAG (Figure 4B).
As expected, all core EJC proteinscoprecipitated with FLAG-BTZ (110–372) (Figure 4B, lane 1). In
contrast, no EJCs formed in the absence of ssRNA and AMP-
PNP, and FLAG-BTZ (110–372) coprecipitated only eIF4A3 (Fig-
ure 4B, lane 5).
Notably, all three eIF4A3 mutants formed recombinant EJCs
as efficiently as the wild-type (Figure 4B, lanes 2–4), clearly
showing that the mutations affect not the ability to interact with
the EJC core but, rather, the splicing-dependent loading of
the complex. Hence, our results identify key residues of eIF4A3
that mediate both the interaction with the MIF4G domain of
CWC22 and the assembly of EJCs by the spliceosome. Together
with previously published data, our work thus redefines the
framework of interactions required for the formation of EJCs in
living cells.
DISCUSSION
Exon junction complexes are important functional mRNP
components that assemble on maturing mRNA during splicing
in the nucleus. In this work, we have identified the protein
Figure 4. The Interaction of eIF4A3 and CWC22 Contributes to Splicing-Dependent EJC Assembly
(A) Analysis of splicing-dependent EJC assembly. Splicing reactions using MINX (top panel) or MINX-GG (mutated 30 splice site, bottom panel) as substrate
mRNA were carried out in splicing extracts composed of HeLa nuclear extracts and 293 whole-cell extracts expressing FLAG-eIF4A3, the indicated mutants of
eIF4A3, or unfused FLAG. FLAG-containing mRNPs were immunoprecipitated, and coprecipitated RNA was separated by denaturing PAGE. Positions of
unspliced precursor transcript, splicing intermediates (MINX-GG), and spliced product (MINX) are indicated schematically. Expression levels of the eIF4A3
mutants were determined by immunoblotting (a-FLAG, bottom).
(B) Analysis of splicing-independent EJC assembly in vitro from recombinant components. Strep-eIF4A3 (wild-type or the indicated mutants), FLAG-BTZ
(110–372)-Strep, Y14-Strep, and MAGOH were incubated under EJC-assembly conditions in the presence (lanes 1–4) or absence (lanes 5–8) of AMP-PNP and
ssRNA. Protein complexes were immunoprecipitated, separated by SDS-PAGE, and stained with Coomassie.
(C) The three-step model of splicing-dependent EJC deposition. For details, see Discussion.
See also Figure S4.CWC22 as a central EJC-assembly factor. CWC22 is an abun-
dant component of the activated spliceosome and the spliceo-
somal C complex (Bessonov et al., 2008). This supports the
prior notion that eIF4A3 is recruited to the spliceosome during
an early step of splicing (Gehring et al., 2009a; Mishler et al.,Cel2008). Considering the molecular architecture of CWC22, its
resemblance to other DExD-box-helicase-interacting proteins
and its exclusive binding to eIF4A3, but not MAGOH and
Y14, we propose a three-step model for EJC assembly
(Figure 4C).l Reports 2, 454–461, September 27, 2012 ª2012 The Authors 459
The binding of eIF4A3 to CWC22 represents the first step of
EJC assembly (step 1). Although biochemically well defined,
more details of this interaction need to be determined; in partic-
ular, whether CWC22 and eIF4A3 are recruited to the spliceo-
some individually or as a heterodimer. Previous studies showed
that the binding of DExD-box helicases (e.g., eIF4A and the
nuclear export factor Dbp5) to their interacting proteins (eIF4G
and Gle1, respectively) stabilizes them in a ‘‘half-open’’ and
activated conformation (Hilbert et al., 2011; Montpetit et al.,
2011; Schu¨tz et al., 2008). We therefore propose that eIF4A3
adopts a similar ‘‘half-open’’ conformation upon binding to
CWC22 (step 2). This activated conformation would prevent
premature RNA binding and prime eIF4A3 for receipt of the
MAGOH-Y14 heterodimer. At the same time, the activated
conformation of eIF4A3 enables it to be loaded to the mRNA in
a single step through a conformational change imposed by
MAGOH-Y14 binding (step 3). However, the molecular details
of the MAGOH-Y14 recruitment to the spliceosome remain
elusive and thus represent an interesting subject for future
research.
The function of CWC22 within the spliceosome of mammalian
cells is poorly understood. Although our data demonstrate that
CWC22 is required for pre-mRNA splicing, its precise role in
this process remains to be determined. Interactions between
CWC22 and two spliceosomal proteins, FAM32A and FRG1,
have been discovered in a large-scale Y2H-screen, but neither
of these direct interaction partners elucidates the role of
CWC22 in splicing (Hegele et al., 2012). Interestingly, the central
part of CWC22 comprising the MIF4G and the MA3 domain, but
not the MIF4G domain alone, is sufficient to rescue the splicing
defect of CWC22-depleted cells. This suggests that an interac-
tion involving the MA3 domain is required for the proper function
of CWC22 during splicing. The yeast ortholog, Cwc22, has been
described as an essential pre-mRNA splicing factor that is
required for the function of Prp2 in promoting the release of
SF3a and SF3b during the first catalytic step of splicing (Yeh
et al., 2011). Similar to human CWC22, the MA3 domain of
Cwc22 is required to rescue the splicing defect of Cwc22
knockout cells (Yeh et al., 2011). In order to shed light on the
splicing function of CWC22, it will be instrumental to identify
interaction partners of Cwc22 and CWC22 within the spliceo-
some that bind specifically to the MA3 domain.
Recently, a specific splicing function of the EJC core proteins
eIF4A3, MAGOH, and Y14 has been described, but the precise
role of the EJC during splicing remains obscure (Ashton-Beau-
cage et al., 2010; Roignant and Treisman, 2010). Considering
the direct interaction between eIF4A3 and CWC22, it is tempting
to speculate that the splicing function of the EJC is mediated via
this molecular contact, although the deposition of EJCs is
presumably not important for the general splicing function of
CWC22.
Our description of the CWC22-eIF4A3 interaction provides
a rationale for the intimate coupling of EJC deposition and
pre-mRNA splicing. The conserved mode of interaction sug-
gests that the activation and loading of eIF4A3 by CWC22 obeys
the rules described for eIF4G, Gle1, and their DExD -box heli-
case interaction partners and proposes a general mechanism
for DEAD-box helicase recruitment. Future studies will provide460 Cell Reports 2, 454–461, September 27, 2012 ª2012 The Authorinsight into the mechanistic and structural details of this inter-
action and reveal additional factors that are employed by the
spliceosome to deposit the EJC.
EXPERIMENTAL PROCEDURES
Cell Culture, Plasmid Transfections, and siRNA Transfections
HeLa cells were grown and transfected with plasmid DNA or siRNA as previ-
ously described (Gehring et al., 2009a). For transfections of b-globin, TPI,
and TCR, we used 1.5 mg reporter plasmid, 1.5 mg LacZ-HBB control plasmid,
0.5 mg rescue plasmid, and 0.3 mg GFP expression vector. Transfections for
immunoprecipitations and 293 whole extracts were performed as previously
described (Gehring et al., 2009a).
RNA Extraction and Analysis
Total RNA was extracted with TRIzol and analyzed by Northern blotting as
previously described (Gehring et al., 2009a).
Immunoblot Analysis and Immunoprecipitation
FLAG-complexes were immunoprecipitated from RNase A (50 mg/ml)- or
RNase I (25 U/ml)-treated HeLa cell lysates with M2 anti-FLAG magnetic
beads (Sigma) at 4C for 2 hr in lysis buffer (50 mM Tris [pH 7.2], 150 mM
NaCl, 0.5% Triton X-100, + protease inhibitor). Beads were washed with lysis
buffer, and complexes were eluted with SDS-sample buffer, separated by
SDS-PAGE, and analyzed by immunoblotting.
In Vitro Transcription, In Vitro Splicing, and RNP
Immunoprecipitation
Capped transcripts were generated by in vitro transcription with SP6 RNA
polymerase in the presence of a32P-GTP and cap analog (Promega). In vitro
splicing reactions were performed in HeLa cell nuclear extract (CIL Biotech)
that was supplemented with 293 whole-cell extracts (Gehring et al., 2009a).
FLAG immunoprecipitations of RNPs were performed with FLAG-M2 affinity
gel in mRNP IP buffer (20 mM HEPES KOH [pH 7.9], 200 mM NaCl, 2 mM
MgCl2, 0.2% Triton X-100, 0.1% NP-40, 0.05% Na-Deoxycholate). RNAs
were recovered by TRIzol extraction and analyzed by denaturing PAGE.
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